APPIRED III clinical study kicked off with first patient recruited
Wageningen, 16 November 2017- Alloksys Life Sciences announced today that its international APPIRED lll clinical study has started with inclusion of the first patient in Eindhoven, the Netherlands. Patients undergoing…